Madrigal Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: MDGL
Share price (9/28/26): $517.04
Market cap (9/28/26): $11.9 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Ownership Filter

Friedman Paul A

Sibold William John

Sibold William John

Sibold William John

Kelley Shannon T

News Filter

Appoints John C. Reed, M.D., Ph.D., to Its Board of Directors

Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Reports First-Quarter 2026 Financial Results and Provides Corporate Updates

Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC